The Elements of Style

ECO Animal Health Appoints Dr. Joachim Hasenmaier as Non-Executive Director

Retrieved on: 
月曜日, 2月 12, 2024
Acquisition, The Elements of Style, Doctor of Philosophy, Boehringer Ingelheim Animal Health, Health, Growth, ECO, Veterinary medicine, MBA, AIM, Vaccine, Boehringer Ingelheim, McKinsey & Company, Animal Health, Mars, Incorporated, Ageing, Management

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with immediate effect.

Key Points: 
  • ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Dr. Joachim Hasenmaier as a Non-Executive Director, with immediate effect.
  • Dr. Hasenmaier is a highly experienced commercial leader with more than two decades in the international animal health industry.
  • From 2001 to 2019 he held a variety of senior roles within the animal health division at Boehringer Ingelheim, concluding as member of the Board of Managing Directors responsible for the entire animal health division.
  • Dr. Andrew Jones, Chairman of ECO, commented: “On behalf of the Board, I am delighted to welcome Joachim as a Non-Executive Director to ECO.

HUTCHMED Announces Changes to Board of Directors and Technical Committee 

Retrieved on: 
木曜日, 7月 13, 2023
The Elements of Style, The Carlyle Group, Goldman Sachs, Hangzhou, Specialised Technical Committees of the African Union, Law, Stock exchange, Special, Attention, Part, Economics, Salubris Pharmaceuticals, Phi Beta Kappa, Business administration, HKEX, Investment, Harvard Business School, Security (finance), General Atlantic, Ageing, Smith College, Master of Business Administration, HK, Management, Property management

The Board of Directors of HUTCHMED (the “Board”) is of the view that the appointment of Ms Yang would provide significant benefits to HUTCHMED taking into consideration her experience in biotechnology company management, business strategy, capital markets and mergers and acquisitions.

Key Points: 
  • The Board of Directors of HUTCHMED (the “Board”) is of the view that the appointment of Ms Yang would provide significant benefits to HUTCHMED taking into consideration her experience in biotechnology company management, business strategy, capital markets and mergers and acquisitions.
  • Carlyle owns approximately 4.7% of the ordinary shares of HUTCHMED, through its affiliate CA Fern Parent.
  • Save for her role with Carlyle, she does not have any relationship with any Directors, senior management or substantial or controlling shareholders of HUTCHMED.
  • Mr Simon To, Chairman of HUTCHMED, said: “The Board warmly welcomes the appointment of Professor Peters as Special Advisor to the Technical Committee, and looks forward to working with her.

Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors

Retrieved on: 
月曜日, 7月 3, 2023
LSE, The Elements of Style, Type 2 diabetes, Chronic kidney disease, Diabetes, Audit committee, California State University, Sarbanes–Oxley Act, Certified Public Accountant, SALT, Schedule, Minerva Surgical, Inc. v. Hologic, Inc., Patient, Risk, Artificial intelligence, Ageing, FDA, Professional Football Compensation Committee, Compensated emancipation, Conditional sentence, Disease, Audit

Ms. Coste was also appointed as the Non-Executive Chair of the Audit Committee and a member of the Renumeration Committee.

Key Points: 
  • Ms. Coste was also appointed as the Non-Executive Chair of the Audit Committee and a member of the Renumeration Committee.
  • Ms. Coste has extensive financial experience having retired from Deloitte and Touche LLP (“Deloitte”) in 2020, where she was a senior partner and served as one of Deloitte’s life sciences industry executive leaders.
  • She spent 32 years in both corporate and professional services positions leading global finance, internal audit and operations teams.
  • During her career at Deloitte, Ms. Coste was directly involved with over 30 life science corporations, the majority of which were large-cap and medium-cap public corporations.

J.P. MORGAN LAUNCHES 24th ANNUAL SUMMER READING LIST

Retrieved on: 
火曜日, 5月 23, 2023
Ginni Rometty, Communication, Natural language processing, Magic, Life, Ageless, Associate, Wilson, Money machine, Child, Acquisition, Weijian Shan, Collection, Inclusive, News, Anecdote, Book, Noise, Librarian, Horse, Culture, Myth, The Elements of Style, Rothschild, Organization, Abstract expressionism, Asian Americans, Axios, Supreme court, Imagination, Woman, Accenture, Anatomy, Business, History, Boys in the Trees (book), Amazon, Beauty, IBM, Food, Painting, The New York Times, Tree, Work, Intelligence, Symbolism, DK, School, Trust, Fortune 500, Artificial intelligence, Wine, Management, Security (finance), Jews, Amazing

NEW YORK, May 23, 2023 /PRNewswire/ -- J.P. Morgan today launched its 24th annual Summer Reading List, a collection of books selected to spark curiosity, inspire new perspectives and unlock potential for the future. With new titles by creative luminaries, admired industry leaders and forward-thinking entrepreneurs, the books invite readers worldwide on a journey from the canopy of the Amazon to the ranches of Wyoming, to the boardrooms of Hong Kong and beyond.

Key Points: 
  • NEW YORK, May 23, 2023 /PRNewswire/ -- J.P. Morgan today launched its 24th annual Summer Reading List, a collection of books selected to spark curiosity, inspire new perspectives and unlock potential for the future.
  • To curate the list, J.P. Morgan Client Advisors worldwide submitted hundreds of non-fiction titles.
  • That list was then culled and reviewed based on timeliness, quality and appeal to the firm's global client base.
  • A summer tradition for over two decades, the 2023 J.P. Morgan Summer Reading List introduces a future-inspired read, selected by and for the next generation.

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committees 

Retrieved on: 
水曜日, 5月 10, 2023
Molecular biology, The Elements of Style, Journal of Thoracic Oncology, Internet Technical Committee, Law, Lung cancer, Oncology, Article, Doctor of Philosophy, European Society for Medical Oncology, Audit committee, Teaching hospital, Professor, Retirement, Journal, University Hospital (Newark, New Jersey), Ageing, Health, Ludwig Cancer Research, Annals of Oncology, Swiss, SIX Swiss Exchange, Teaching, International Association, Research, Attention, Annals, Security (finance), Editor-in-chief, Woman, Swiss Federal Institute of Technology, ESMO, Medicine, NSCLC, US, HKEX, Letter, Swiss Federal Institute of Aquatic Science and Technology, Part, University of Lausanne, Galenica, Strategic Advisory Board for Intellectual Property Policy, HK, Management, Nursing

The Board of HUTCHMED is of the view that Professor Peters will make significant contributions to the Company.

Key Points: 
  • The Board of HUTCHMED is of the view that Professor Peters will make significant contributions to the Company.
  • Mr Simon To, Chairman of HUTCHMED said “On behalf of the Board, I would like to extend a warm welcome to Professor Peters to the Company.
  • Professor Peters is also an independent director of Galenica AG, which is listed on the SIX Swiss Exchange.
  • The director’s fees of Professor Peters as an Independent Non-executive Director, member of the Technical Committee and member of the Audit Committee of the Company under her appointment letter are US$76,000, US$8,000 and US$13,500 per annum respectively.

Appointment of Non–Executive Director

Retrieved on: 
月曜日, 5月 16, 2022
Part, Company, General Atlantic, The Elements of Style, Law, HCM, AGM, Stock exchange, LinkedIn, Cancer, Security (finance)

Under the terms of the appointment of Mr Sun as a non-executive director of the Company until the next AGM, he has agreed that he will not receive any fee for his service and that his appointment will be renewed for successive 12-month periods, unless he is not re-elected at the next AGM or his appointment is otherwise terminated earlier by either party in writing.

Key Points: 
  • Under the terms of the appointment of Mr Sun as a non-executive director of the Company until the next AGM, he has agreed that he will not receive any fee for his service and that his appointment will be renewed for successive 12-month periods, unless he is not re-elected at the next AGM or his appointment is otherwise terminated earlier by either party in writing.
  • Save for the appointments listed above, Mr Sun has held no other directorships during the period of five years prior to his appointment as a director of HUTCHMED.
  • Save for his role with General Atlantic, Mr Sun does not have any relationship with any Directors, senior management or substantial or controlling shareholders of HUTCHMED.
  • It has more than 4,600 personnel across all its companies, at the center of which is a team of about 1,700 in oncology/immunology.

Falcon Oil & Gas Ltd. - Board Changes

Retrieved on: 
火曜日, 5月 3, 2022
Board, Beetaloo, Noriyuki Abe, Company, Canadian Society of Petroleum Geologists, PricewaterhouseCoopers, University, AIM, Senior, Chartered accountant, Â, AAPG, Moses Austin, Time, Adobe Inc., Joachim, CFO, Petroleum, Association, Heytesbury Pty. Ltd., American Association, Knowledge, Burlington Resources, The Elements of Style, Chesapeake Energy, Key Stage 3, Exxon, FOG, VP, Management

03 May 2022 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to confirm the appointment of Tom Layman as a Non-Executive Director and to the Board of the Company (the Board).

Key Points: 
  • 03 May 2022 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is pleased to confirm the appointment of Tom Layman as a Non-Executive Director and to the Board of the Company (the Board).
  • In conjunction with these appointments, Daryl Gilbert and JoAchim Conrad have retired as Non-Executive Directors from the Board.
  • Tom Layman is a certified petroleum geologist with over 40 years experience in the oil and gas industry.
  • Falcon Exploration And Production South Africa (Pty) Ltd.
    At the date of this announcement,Anne Flynnholds 200,000 ordinary shares in the capital of the Company.

Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors

Retrieved on: 
水曜日, 3月 30, 2022
Chronic kidney disease, Biomarker, DKD, NASDAQ, Dialysis, CDC, Public health, Genetics, Centers for Disease Control and Prevention, Breast, Kidney disease, Food, EHR, The Elements of Style, CKD, LSE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Physician, Center, Risk assessment, Patient, AIM, Prognosis, Pharmaceutical industry

Save for the disclosures above, there are no further disclosures to be made in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules.

Key Points: 
  • Save for the disclosures above, there are no further disclosures to be made in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules.
  • Kidney disease is now recognized as a public health epidemic affecting over 850 million people globally.
  • The Centers for Disease Control and Prevention (CDC) estimates that 15% of US adults, or 37 million people, currently have chronic kidney disease (CKD).
  • The company has engineered a new solution that enables early-stage chronic kidney disease progression risk assessment.